Levetiracetam 500 MG Oral Tablet
1 INDICATIONS AND USAGE Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older ( 1.1 ) Levetiracetam is indicated for adjunctive therapy for the treatment of: Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy ( 1.2 ) Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy ( 1.3 ) 1.1 Partial-Onset Seizures Levetiracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. 1.2 Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy Levetiracetam tablets are indicated as adjunctive therapy for the treatment of myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy. 1.3 Primary Generalized Tonic-Clonic Seizures Levetiracetam tablets are indicated as adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy.
Torrent Pharmaceuticals Limited
OVAL YELLOW 500 MG 1015
500 MG 1015 OVAL YELLOW
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
LEVETIRACETAM 250 mg tablets, USP are blue colored, oval shaped, film-coated tablets debossed with breakline separating '250' and 'MG' on one side and '1014' on other side. They are supplied as: Bottle of 60 NDC -13668-014-60 Bottle of 120 NDC -13668-014-12 Bottle of 250 NDC -13668-014-25 Bottle of 500 NDC -13668-014-05 Bottle of 2500 NDC -13668-014-31
LEVETIRACETAM 500 mg tablets, USP are yellow colored, oval shaped, film-coated tablets debossed with breakline separating '500' and 'MG' on one side and '1015' on other side. They are supplied as: Bottle of 60 NDC -13668-015-60 Bottle of 120 NDC -13668-015-12 Bottle of 250 NDC -13668-015-25 Bottle of 500 NDC -13668-015-05 Bottle of 1350 NDC -13668-015-17
LEVETIRACETAM 750 mg tablets, USP are orange colored, oval shaped, film-coated tablets debossed with breakline separating '750' and 'MG' on one side and '1016' on other side. They are supplied as: Bottle of 60 NDC -13668-016-60 Bottle of 120 NDC -13668-016-12 Bottle of 250 NDC -13668-016-25 Bottle of 500 NDC -13668-016-05 Bottle of 800 NDC -13668-016-67
LEVETIRACETAM 1000 mg tablets, USP are white to off white, oval shaped, film-coated tablets debossed with breakline separating '1000' and 'MG' on one side and '1017' on other side. They are supplied as: Bottle of 60 NDC -13668-017-60 Bottle of 120 NDC -13668-017-12 Bottle of 250 NDC -13668-017-25 Bottle of 500 NDC -13668-017-05 Bottle of 650 NDC -13668-017-65 16.2 Storage Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container with a child-resistant closure.
More pills like OVAL 500 MG 1015